Literature DB >> 33902592

Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial-mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2.

Zhenming Jiang1, Yuxi Zhang2,3, Xi Chen4, Pingeng Wu1, Dong Chen5.   

Abstract

BACKGROUND: Prostate cancer (PCa) is a common disease that often occurs among older men and a frequent cause of malignancy associated death in this group. microRNA (miR)-129-5p has been identified as an essential regulator with a significant role in the prognosis of PC. Therefore, this study aimed to investigate roles of miR-129-5p in PCa.
METHODS: Microarray analysis was conducted to identify PCa-related genes. The expression of miR-129-5p and ZIC2 in PCa tissues was investigated. To understand the role of miR-129-5p and ZIC2 in PCa, DU145 cells were transfected with mimic or inhibitor of miR-129-5p, or si-ZIC2 and the expression of Wnt, β-catenin, E-cadherin, vimentin, N-cadherin, vascular endothelial growth factor (VEGF), and CD31, as well as the extent of β-catenin phosphorylation was determined. In addition, cell proliferation, migration, invasion, angiogenesis, apoptosis and tumorigenesis were detected.
RESULTS: miR-129-5p was poorly expressed and ZIC2 was highly expressed in PCa tissues. Down-regulation of ZIC2 or overexpression of miR-129-5p reduced the expression of ZIC2, Wnt, β-catenin, N-cadherin, vimentin, and β-catenin phosphorylation but increased the expression of E-cadherin. Importantly, miR-129-5p overexpression significantly reduced cell migration, invasion, angiogenesis and tumorigenesis while increasing cell apoptosis.
CONCLUSIONS: The findings of the present study indicated that overexpression of miR-129-5p or silencing of ZIC2 could inhibit epithelial-mesenchymal transition (EMT) and angiogenesis in PCa through blockage of the Wnt/β-catenin signaling pathway.

Keywords:  Angiogenesis; Epithelial–mesenchymal transition; Prostate cancer; Wnt/β-catenin signaling pathway; Zinc-finger protein of the cerebellum 2; microRNA-129-5p

Year:  2019        PMID: 33902592     DOI: 10.1186/s12935-019-0977-9

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  45 in total

Review 1.  SnapShot: Prostate cancer.

Authors:  Lamont J Barlow; Michael M Shen
Journal:  Cancer Cell       Date:  2013-09-09       Impact factor: 31.743

Review 2.  Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs.

Authors:  Samy Lamouille; Deepa Subramanyam; Robert Blelloch; Rik Derynck
Journal:  Curr Opin Cell Biol       Date:  2013-02-20       Impact factor: 8.382

Review 3.  Angiogenesis and anti-angiogenic therapy in prostate cancer.

Authors:  Deborah Mukherji; Sally Temraz; David Wehbe; Ali Shamseddine
Journal:  Crit Rev Oncol Hematol       Date:  2013-01-29       Impact factor: 6.312

Review 4.  Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.

Authors:  Robert D Loberg; Christopher J Logothetis; Evan T Keller; Kenneth J Pienta
Journal:  J Clin Oncol       Date:  2005-11-10       Impact factor: 44.544

5.  Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.

Authors:  Christelle P El-Haibi; Rajesh Singh; Pranav Gupta; Praveen K Sharma; Krysta N Greenleaf; Shailesh Singh; James W Lillard
Journal:  J Proteomics Bioinform       Date:  2012

Review 6.  MicroRNA control of epithelial-mesenchymal transition and metastasis.

Authors:  Jinsong Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

7.  Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.

Authors:  Jianwei Zhang; Youlin Kuang; Yan Wang; Quanquan Xu; Qinghua Ren
Journal:  Apoptosis       Date:  2017-06       Impact factor: 4.677

Review 8.  Prostate cancer: screening, diagnosis and management in 2007.

Authors:  Robert L Grubb; Adam S Kibel
Journal:  Mo Med       Date:  2007 Sep-Oct

Review 9.  Prostate Cancer for the Internist.

Authors:  Shikha Jaiswal; Rehan Sarmad; Sumant Arora; Radhikha Dasaraju; Komal Sarmad
Journal:  N Am J Med Sci       Date:  2015-10

Review 10.  Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer.

Authors:  Sven Perner; Marcus V Cronauer; Andres Jan Schrader; Helmut Klocker; Zoran Culig; Aria Baniahmad
Journal:  Oncotarget       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.